VOYA Investment Management
CNCE

VOYA Investment Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

VOYA Investment Management’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-37,297
Closed -$186K – 2929
2021
Q1 		$186K Buy
37,297
+23,981
+180% +$194K ﹤0.01% 2562
2020
Q4 		$168K Buy
13,316
+3,233
+32% +$36.9K ﹤0.01% 2473
2020
Q3 		$99K Hold
10,083
– – ﹤0.01% 2345
2020
Q2 		$100K Sell
10,083
-2,977
-23% -$28.6K ﹤0.01% 2337
2020
Q1 		$115K Buy
13,060
+1,319
+11% +$13K ﹤0.01% 2307
2019
Q4 		$108K Buy
+11,741
New +$83.2K ﹤0.01% 2529
2018
Q2 		– Sell
-8,778
Closed -$201K – 2657
2018
Q1 		$201K Hold
8,778
– – ﹤0.01% 2315
2017
Q4 		$227K Buy
+8,778
New +$177K ﹤0.01% 2279

Other funds holding CNCE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VOYA Investment Management's CNCE Position: Q2 2021 in Review

VOYA Investment Management sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q2 2021, closing a stake of 37,297 shares — an estimated $186K sold.

VOYA Investment Management first reported a position in CNCE in Q4 2017 and held it in 8 quarters. The position peaked at $227K in Q4 2017. 79 funds tracked by Wall St. Rank hold CNCE as of Q2 2021.

  • VOYA Investment Management reported no remaining Concert Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • VOYA Investment Management sold 37,297 Concert Pharmaceuticals, Inc. shares in Q2 2021, an estimated $186K.
  • VOYA Investment Management first reported a position in Concert Pharmaceuticals, Inc. in Q4 2017 and held it in 8 quarters.
  • VOYA Investment Management's Concert Pharmaceuticals, Inc. position peaked at $227K in Q4 2017.
  • 79 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q2 2021.

Based on VOYA Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.